Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Canadian authorities assessing reimbursement for newly approved cystic fibrosis treatment Kalydeco

Dec. 4, 2012

Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee

Nov. 13, 2012

Health Canada approves Seebri Breezhaler for COPD

Oct. 23, 2012

Health Canada approves new drug submission for Cinryze

Oct. 23, 2012

New safety information for Zofran issued in Canada

Oct. 10, 2012

Apricus Biosciences plans Canadian submission for MycoVa

Oct. 2, 2012

Health Canada approves Dermagraft for diabetic foot ulcers

Sep. 7, 2012

Health Canada approves Treanda

Aug. 29, 2012

Tarceva approved in Canada for specific NSCLC subtype

Aug. 14, 2012

Xiaflex approved in Canada

July 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...